These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34511970)

  • 1. Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients.
    Alaiya A; Alshukairi A; Shinwari Z; Al-Fares M; Alotaibi J; AlOmaim W; Alsharif I; Bakheet R; Alharbi L; Allam R; Asiri A; Memish Z; Alromaih K; Al-Mozaini M
    J Inflamm Res; 2021; 14():4313-4328. PubMed ID: 34511970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.
    Wu YH; Yeh IJ; Phan NN; Yen MC; Hung JH; Chiao CC; Chen CF; Sun Z; Hsu HP; Wang CY; Lai MD
    J Microbiol Immunol Infect; 2021 Oct; 54(5):845-857. PubMed ID: 34176764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19.
    Jha PK; Vijay A; Halu A; Uchida S; Aikawa M
    Front Cardiovasc Med; 2020; 7():623012. PubMed ID: 33521069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current therapeutic options for coronavirus disease 2019 (COVID-19)-lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol.
    Zhang ZL; Zhong H; Liu YX; Le KJ; Cui M; Yu YT; Gu ZC; Gao Y; Lin HW
    Ann Transl Med; 2020 Nov; 8(22):1527. PubMed ID: 33313272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma proteomics identify potential severity biomarkers from COVID-19 associated network.
    Sahin AT; Yurtseven A; Dadmand S; Ozcan G; Akarlar BA; Kucuk NEO; Senturk A; Ergonul O; Can F; Tuncbag N; Ozlu N
    Proteomics Clin Appl; 2023 Mar; 17(2):e2200070. PubMed ID: 36217943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
    Noor R
    Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
    Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
    J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury.
    Sims AC; Mitchell HD; Gralinski LE; Kyle JE; Burnum-Johnson KE; Lam M; Fulcher ML; West A; Smith RD; Randell SH; Metz TO; Sheahan TP; Waters KM; Baric RS
    mBio; 2021 Aug; 12(4):e0157221. PubMed ID: 34372702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.
    Kohli A; Sauerhering L; Fehling SK; Klann K; Geiger H; Becker S; Koch B; Baer PC; Strecker T; Münch C
    Life Sci Alliance; 2022 May; 5(5):. PubMed ID: 35110370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of coronavirus disease 2019 in children: a systemic review of severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019].
    He Y; Tang J; Zhang M; Wang HR; Li WX; Xiong T; Li YP; Mu DZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Aug; 22(8):844-853. PubMed ID: 32800031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of viral load and antibody response in relation to COVID-19 severity.
    Wang Y; Zhang L; Sang L; Ye F; Ruan S; Zhong B; Song T; Alshukairi AN; Chen R; Zhang Z; Gan M; Zhu A; Huang Y; Luo L; Mok CKP; Al Gethamy MM; Tan H; Li Z; Huang X; Li F; Sun J; Zhang Y; Wen L; Li Y; Chen Z; Zhuang Z; Zhuo J; Chen C; Kuang L; Wang J; Lv H; Jiang Y; Li M; Lin Y; Deng Y; Tang L; Liang J; Huang J; Perlman S; Zhong N; Zhao J; Malik Peiris JS; Li Y; Zhao J
    J Clin Invest; 2020 Oct; 130(10):5235-5244. PubMed ID: 32634129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
    Hui DS; Memish ZA; Zumla A
    Curr Opin Pulm Med; 2014 May; 20(3):233-41. PubMed ID: 24626235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association between exposure to Middle East Respiratory Syndrome (MERS) and mortality rate of Coronavirus Disease 2019 (COVID-19).
    Naeem U; Naeem A; Naeem MA; Naeem K; Mujtaba B; Mujtaba A; Khurshid A
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9172-9181. PubMed ID: 32965011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation.
    Thornbrough JM; Jha BK; Yount B; Goldstein SA; Li Y; Elliott R; Sims AC; Baric RS; Silverman RH; Weiss SR
    mBio; 2016 Mar; 7(2):e00258. PubMed ID: 27025250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of two human-to-human transmitted coronaviruses: Corona Virus Disease 2019 vs. Middle East Respiratory Syndrome Coronavirus.
    Xu P; Sun GD; Li ZZ
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5797-5809. PubMed ID: 32495918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.
    Lau SKP; Lau CCY; Chan KH; Li CPY; Chen H; Jin DY; Chan JFW; Woo PCY; Yuen KY
    J Gen Virol; 2013 Dec; 94(Pt 12):2679-2690. PubMed ID: 24077366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS.
    Aljabr W; Alruwaili M; Penrice-Randal R; Alrezaihi A; Harrison AJ; Ryan Y; Bentley E; Jones B; Alhatlani BY; AlShahrani D; Mahmood Z; Rickett NY; Alosaimi B; Naeem A; Alamri S; Alsran H; Hamed ME; Dong X; Assiri AM; Alrasheed AR; Hamza M; Carroll MW; Gemmell M; Darby A; Donovan-Banfield I; Stewart JP; Matthews DA; Davidson AD; Hiscox JA
    mSphere; 2021 Aug; 6(4):e0021921. PubMed ID: 34287009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.